NCT01647490

Brief Summary

This study is a long-term, prospective, and controlled evaluation of the mechanical dyssynchrony induced by right ventricular apical pacing, both in acute (spontaneous and stimulated) and chronic (12 and 24 months); the study also evaluates the benefit of an alternative pacing site through measures of dyssynchrony in acute and chronic.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
408

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2012

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 19, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 23, 2012

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

July 23, 2012

Status Verified

July 1, 2012

Enrollment Period

1.2 years

First QC Date

July 19, 2012

Last Update Submit

July 19, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • LV dyssynchrony as measured by Electromechanical delay (EMD

    The primary outcome measure of this study is to compare the effect of RV Septal (RVS) versus RV Apical (RVA) pacing as measured by echocardiographic/Doppler Index

    2 weeks

Secondary Outcomes (6)

  • Number of heart failure-related hospitalization

    24 months

  • Right ventricular lead and total implant procedure time, fluoroscopy time

    Implant

  • Change from baseline in R wave in 12-lead ECG

    24 months

  • Absolute change in LVEF

    24 months

  • LV dyssynchrony as measured by Electromechanical delay (EMD)

    24 months

  • +1 more secondary outcomes

Study Arms (2)

Right Ventricular Apex (RVA)

ACTIVE COMPARATOR

In the RVA group the right ventricular pacing lead will be implanted in the apex region of the right ventricle

Procedure: Permanent Cardiac Pacemaker Implantation

Right Ventricular Septum (RVS)

EXPERIMENTAL

In the RVS group the right ventricular pacing lead will be implanted in the septal region (mid septum) of the right ventricle

Procedure: Permanent Cardiac Pacemaker Implantation

Interventions

Right Ventricular Apex (RVA)Right Ventricular Septum (RVS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • indication for a dual chambers cardiac pacemaker device (DDD/DR) according to current guidelines
  • Patients who are able to understand and sign an informed written consent
  • Patients who will conduct the follow-up in the center for at least 24 months
  • Patients age ≥ 18

You may not qualify if:

  • Patients with chronic atrial fibrillation or atrial arrhythmias not controlled within 90 days before enrollment
  • Pre-existing permanent cardiac pacemaker (PM), defibrillator (ICD) or cardiac resynchronization therapy device (CRT)
  • Unplanned or emergency access to the hospital and / or inability to measure the dyssynchrony for the absence of spontaneous rhythm
  • Patients participating in other studies that clearly impact the clinical practice of the center or whose protocol would conflict or affect the outcome of this study
  • Patient not expected to survive for the duration of the study follow-up due to co-morbid medical condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Azienda Ospedaliero Universitaria "Vittorio Emanuele"

Catania, 95124, Italy

RECRUITING

Ospedale Santa Maria di Loreto Mare

Naples, 80142, Italy

RECRUITING

Related Publications (2)

  • Muto C, Calvi V, Botto GL, Pecora D, Porcelli D, Costa A, Ciaramitaro G, Airo Farulla R, Rago A, Calvanese R, Baratto MT, Reggiani A, Giammaria M, Patane S, Campari M, Valsecchi S, Maglia G. Chronic Apical and Nonapical Right Ventricular Pacing in Patients with High-Grade Atrioventricular Block: Results of the Right Pace Study. Biomed Res Int. 2018 May 22;2018:1404659. doi: 10.1155/2018/1404659. eCollection 2018.

  • Muto C, Calvi V, Botto GL, Pecora D, Ciaramitaro G, Valsecchi S, Malacrida M, Maglia G. Is there a right place to pace the right ventricle? Evaluation of apical and septal positions in a pacemaker population: study protocol for a prospective intervention-control trial. Contemp Clin Trials. 2014 Nov;39(2):320-6. doi: 10.1016/j.cct.2014.10.006. Epub 2014 Oct 22.

MeSH Terms

Conditions

BradycardiaHeart BlockSick Sinus Syndrome

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsCardiac Conduction System DiseaseArrhythmia, Sinus

Study Officials

  • Carmine Muto, MD

    Ospedale Santa Maria di Loreto Mare

    STUDY CHAIR
  • Valeria Calvi, MD

    Azienda Ospedaliero Universitaria "Vittorio Emanuele" - Ferrarotto

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Electrophysiology and Pacing Unit Director

Study Record Dates

First Submitted

July 19, 2012

First Posted

July 23, 2012

Study Start

April 1, 2012

Primary Completion

July 1, 2013

Study Completion

July 1, 2015

Last Updated

July 23, 2012

Record last verified: 2012-07

Locations